Article info
PDFReview
Low-grade serous ovarian carcinoma: an evolution toward targeted therapy
- Correspondence to Dr Ioannis A Voutsadakis, Sault Area Hospital, Sault Sainte Marie, ON P6B 0A8, Canada; ivoutsadakis{at}yahoo.com
Citation
Low-grade serous ovarian carcinoma: an evolution toward targeted therapy
Publication history
- Received August 12, 2019
- Revision received September 16, 2019
- Accepted September 24, 2019
- First published November 27, 2019.
Article Versions
- You are currently viewing a Previous version of this article (6 October 2020).
- View the most recent version of this article
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2019. No commercial re-use. See rights and permissions. Published by BMJ.